Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

TrueBlue (TBI) EBITDA (2016 - 2025)

TrueBlue (TBI) has disclosed EBITDA for 17 consecutive years, with -$31.4 million as the latest value for Q4 2025.

  • On a quarterly basis, EBITDA fell 127.59% to -$31.4 million in Q4 2025 year-over-year; TTM through Dec 2025 was -$47.4 million, a 62.73% increase, with the full-year FY2025 number at -$47.4 million, up 62.73% from a year prior.
  • EBITDA was -$31.4 million for Q4 2025 at TrueBlue, down from -$2.1 million in the prior quarter.
  • In the past five years, EBITDA ranged from a high of $22.3 million in Q2 2022 to a low of -$104.5 million in Q2 2024.
  • A 5-year average of -$3.5 million and a median of -$1.5 million in 2023 define the central range for EBITDA.
  • Peak YoY movement for EBITDA: soared 361.58% in 2021, then crashed 1432.77% in 2024.
  • TrueBlue's EBITDA stood at $20.1 million in 2021, then tumbled by 63.06% to $7.4 million in 2022, then plummeted by 129.54% to -$2.2 million in 2023, then tumbled by 528.64% to -$13.8 million in 2024, then plummeted by 127.59% to -$31.4 million in 2025.
  • Per Business Quant, the three most recent readings for TBI's EBITDA are -$31.4 million (Q4 2025), -$2.1 million (Q3 2025), and $475000.0 (Q2 2025).